VSS, CPL and DZIC drafted the paper
The current guidance states that this should be 1 month for Mounjaro, and at least 2 months for Wegovy, Ozempic, and Rybelsus*
PMID: 166
Is that you may see more step therapy and prior authorization, and even removal of drugs, like exclusion of drugs from formularies, because the incentive is going to be for them to really ratchet down the benefit, because theyre not going to be able to either pass the cost to the government, they cant charge the patients anymore, and they cant increase the premiums, which are three great things for patients
Common side effects usually happen in the first few weeks as your body adjusts
Currently, Rybelsus (Semaglutide) is not recommended for pregnant women